Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryce Kirby

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|April 27, 2026
The one-week automated genome-wide optical pooled screenBryce Kirby, Matteo Di Bernardo, Iain M Cheeseman, et al.
Genome Biology|July 3, 2026
A one-week automated genome-wide optical pooled screen using OttoSeqBryce Kirby, Matteo Di Bernardo, Iain M Cheeseman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive CancerMing Zhao, Stephen Scott, Kurt W Evans, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|April 27, 2026
The one-week automated genome-wide optical pooled screenBryce Kirby, Matteo Di Bernardo, Iain M Cheeseman, et al.
Genome Biology|July 3, 2026
A one-week automated genome-wide optical pooled screen using OttoSeqBryce Kirby, Matteo Di Bernardo, Iain M Cheeseman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive CancerMing Zhao, Stephen Scott, Kurt W Evans, et al.
Pageof 1